Skip to main content

Table 3 Treatment details of 533 aneurysms

From: Neuroform atlas stent treatment for 533 intracranial aneurysms in a large Chinese cohort: complication risk factor analysis

Procedural characteristics

Frequency (N = 533 aneurysms)

NeuroForm Atlas Stent size

 Diameter (mm)

3.37 ± 0.55

 Length (mm)

18.34 ± 3.55

Multiple NeuroForm Atlas Stent used

21 (3.9%)

Single NeuroForm Atlas Stent used

512 (96.1%)

Blood thinners

 Preoperative aspirin/clopidogrel > 3 days

439/522 (84.1%)

 Preoperative statin > 7 days

111/522 (21.3%)

 Preoperative anticoagulant (Warfarin/ Rivaroxaban) > 7 days

5/522 (1.0%)

Pre-operation parent artery stenosis

33 (6.2%)

Coil protrusion

18 (3.4%)

Treatment

 Stent-assisted coiling

532 (99.8%)

 Stent

1 (0.2%)

Aneurysm occlusion statusa (Immediate postoperative)

 

 Complete occlusion

397 (74.5%)

 Incomplete occlusion

136 (25.5%)

Procedure duration(mins)b

152.83 ± 42.40

Clinical outcomes

MRS score

 Preoperative mRS score

 

 0–2

502/522 (96.2%)

 3–6

20/522 (3.8%)

 Postoperative mRS score (< 30 d)

 0–2

483/522 (92.5%)

 3–6

39/522 (7.5%)

  1. Data are shown as n (%), n/N (%), or the mean ± SD
  2. * The total number of NeuroForm Atlas Stents used was 554
  3. a Records of operative duration were missing for 81 patients
  4. bEach Aneurysm was evaluated using the Raymond–Roy occlusion classification (RROC) and dichotomized as occluded (I) or residual (II/III)